CClinicalTrials.gg
RecruitingNCT00527839Updated Feb 12, 2026

Hospital for Special Surgery Shoulder Arthroplasty Cohort

An observational study in Shoulder Arthroplasty, sponsored by Hospital for Special Surgery, New York. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-12.

Sponsored by Hospital for Special Surgery, New York · Observational

Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
250
Ages
18 Years and older
Sex
All
01

Study summary

Total joint replacements are some of the most successful medical devices developed over the last fifty years. They enable millions of people to remain ambulatory and pain free, with minimal risk. In 2002, over 200,000 total hip replacements, 350,000 total knee replacements, and 25,000 total or partial shoulder replacements were performed in the United States (HCUP data). Future use will likely be even higher: it is estimated that by the year 2020, the population 65 and over in developed countries will increase by 71%. Existing studies do not provide adequate prospective data to evaluate long-term outcomes.

HSS is a world leader in total joint replacement including total shoulder arthroplasty. However, there is no systematic follow-up or evaluation of patients who have their shoulders replaced here.

The purpose of this study is to establish a prospective cohort of HSS total shoulder arthroplasty to evaluate predictors of outcome, causes of failure and to allow ongoing evaluation of the results of our patients over time.

02

Conditions studied

  • Shoulder Arthroplasty
03

In context

Lead sponsor

Hospital for Special Surgery, New York is the lead sponsor of 217 studies on the registry; 39 are open to participants now.

Of its 27 completed or terminated interventional studies of FDA-regulated products, 20 (74%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

We will be asking all patients undergoing a total shoulder arthroplasty to participate.

Inclusion criteria

  • 18 years or older and undergoing total shoulder arthroplasty at HSS

Exclusion criteria

Exclusion Criteria:

  • No other exclusion criteria. Pregnant women are eligible for the registry as this is a non-interventional study which only involves filling out questionnaires.
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
250 participants (estimated)
06

What researchers measure

Primary outcomes

  1. Patient Reported Outcome Measures (PROMs)

    Patient reported outcomes (PROMs) at 1 year, 2 year, 5 year, 10 year follow-up time points. This information will be collected and maintained for use in future research studies with their own individually defined outcomes.

    Time frame: Collection of at Baseline, 6 Months, 1 Year, 2 Year, 5 Year and 10 Year

  2. Intra Operative Data

    Surgeon reported data

    Time frame: Collection of data on Day 0 (Date of Surgery)

  3. Demographic data

    Collection of patient information and demographic data

    Time frame: Collection of at Baseline, 6 Months, 1 Year, 2 Year, 5 Year and 10 Year

07

Study locations

2 of 2 sites recruiting
  • Hospital for Special Surgery
    New York, New York 10021, United States
    • Gina Aharonoff, MS · Contact · aharonoffg@hss.edu · 646-797-8904
    • Kaitlyn Lillemoe · Contact · lillemoek@hss.edu
    • Lisa Mandl, MD · Sub investigator
    • Thomas Sculco, MD · Sub investigator
    • Robert Marx, MD · Principal investigator
    • Stephen Lyman, PhD · Sub investigator
    • Alvin Mushlin, MD,ScM · Sub investigator
    • Hassan Ghomrawi, PhD · Sub investigator
    • Stephen Incavo, MD · Sub investigator
    • John Rutledge · Sub investigator
    • Jason Guardado · Sub investigator
    • Madhu Mazumdar, PhD · Sub investigator
    • Stephen Goldring, MD · Sub investigator
    • Renee Razzano, MA · Sub investigator
    • Jo Hannafin, MD,PhD · Sub investigator
    • Gina Aharonoff · Sub investigator
    • Andrew Weiland, MD · Sub investigator
    • Answorth A Allen, MD · Sub investigator
    • David Altchek, MD · Sub investigator
    • Struan H Coleman, MD, PhD · Sub investigator
    • Frank Cordasco, MD · Sub investigator
    • Edward V Craig, MD · Sub investigator
    • David M Dines, MD · Sub investigator
    • Stephen Fealy, MD · Sub investigator
    • Anne Kelly, MD · Sub investigator
    • Bryan Kelly, MD · Sub investigator
    • John D MacGillivray, MD · Sub investigator
    • Michael Maynard, MD · Sub investigator
    • Stephen J O'Brien, MD · Sub investigator
    • Andrew D Pearle, MD · Sub investigator
    • Beth Shubin Stein, MD · Sub investigator
    • Scott Rodeo, MD · Sub investigator
    • Howard A Rose, MD · Sub investigator
    • Russell F Warren, MD · Sub investigator
    • Thomas L Wickiewicz, MD · Sub investigator
    • Riley J Williams, MD · Sub investigator
    • Kenneth Mathis, MD · Sub investigator
    • Nadia Camille · Sub investigator
    • Justine Shum · Sub investigator
    • Tamara Hagoel · Sub investigator
    • Daniel Fischer · Sub investigator
    • Kaitlyn Lillemoe · Sub investigator
    • Nam Giang · Sub investigator
    • Huong Do, MS · Sub investigator
    Recruiting
  • Hospital for Special Surgery
    New York, New York 10021, United States
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00527839
Lead sponsor
Hospital for Special Surgery, New York
Responsible party
Sponsor
First posted
Sep 11, 2007
Start date
Apr 2007
Primary completion
Apr 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Feb 12, 2026

Study contacts

Robert Marx, MD
Contact
marxr@hss.edu
212-606-1645
Anthony Finocchiaro, BA
Contact
finocchiaroa@hss.edu
(212)774 - 7524
Robert Marx, MD
principal investigator · Hospital for Special Surgery, New York

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion